Understanding seasonal vaccines efforts far beyond the vaccination season

Manufacturers

A tsunami of regulations will require biopharma to look to the high ground of knowledgeable partners

Manufacturers

Understanding how to energize, extend and capitalize the lifespan of mature drugs

Manufacturers

Collaborative partnerships key to clearing the path for new biopharma products

Manufacturers

Pharmacy Network Strategies

Manufacturers

Q&A – How the tendency towards decentralized supply chains has changed in CGT

Manufacturers

Changing Channels

Animal Health

Prioritizing sustainability in your veterinary practice

Manufacturers

Post-launch checklist: What to look for in a commercialization partner

Manufacturers

Recap Asembia 2023: Our impactful contributions to the premier specialty pharmacy conference

Pharmacies

3 ways your distributor can help you prepare for DSCSA compliance

Manufacturers

The essential guide to drug commercialization

Pharmacies

DSCSA: Are you ready for November 2024?

Manufacturers

Three questions biopharma companies must ask when building a cell and gene commercialization strategy

Pharmacies

How are retail prescriptions captured into the 340B program?

Manufacturers

What to consider when building a channel strategy for a rare disease product

Animal Health

How Destination Pet redefined practice autonomy for its financial benefit

Animal Health

How Destination Pet redefined practice autonomy for its financial benefit

Manufacturers

Nine questions about rare and orphan drug commercialization

Manufacturers

Working with government entities to advance access, affordability, and supply chain stability

Manufacturers

Webinar: Rethink your commercialization strategy

Pharmacies

Four things large retail pharmacies should look for in a distribution partner

Manufacturers

Webinar: Commercial supply chain strategies for cell and gene therapies

Manufacturers

Webinar | Cell and gene therapies: Clinical supply chain considerations

Animal Health

Managing indirect costs of inventory management in veterinary practices

Pharmacies

Five ways distributors should dream big for pharmacy partners

Manufacturers

Innomar Strategies: 20 years of innovative market access solutions

Physician Practices

Supporting flu vaccine access

Manufacturers

On-demand webinar: Success factors for commercializing rare disease and orphan drugs

Manufacturers

The hidden value of integrated commercialization services: A manufacturer’s perspective

Manufacturers

Ebook: Strategic partnerships for unlocking product potential

Manufacturers

On demand webinar: Considerations for the commercialization of cell and gene therapies

Manufacturers

How to make the most of integrated commercialization solutions

Manufacturers

Ebook: Virtual drug commercialization

Manufacturers

The road to a COVID-19 treatment launch

Manufacturers

Five growth drivers for the consumer healthcare products market

Manufacturers

Infographic: navigating health policy

Pharmacies

Spotlight: The corporate partnerships model

Pharmacies

Driving deeper customer relationships

Physician Practices

How Community and Specialty Physician Practices Are Confronting COVID-19 Challenges

Pharmacies

How Do Allocations Work for the Pharma Supply Chain?

Manufacturers

How the Pharma Supply Chain is Responding to COVID-19

Manufacturers

Preparing for DSCSA Interoperability

Manufacturers

Rethink: Channel Strategy for Oral Oncolytics

Health Systems

Commercially Available Unit Dose Products: Enhancing Access to Treatments and Promoting Pharmacy Efficiency

Manufacturers

A New Approach to Channel Strategy for Oncology Therapies

Manufacturers

Improving Customer Experience and Driving Long-Term Value for Manufacturers